(TTMI) TTM Technologies - Overview
Stock: Printed Circuit Boards, RF Components, Microwave Assemblies, Mission
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 72.7% |
| Relative Tail Risk | -12.3% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.29 |
| Alpha | 272.55 |
| Character TTM | |
|---|---|
| Beta | 1.834 |
| Beta Downside | 1.773 |
| Drawdowns 3y | |
|---|---|
| Max DD | 34.24% |
| CAGR/Max DD | 2.71 |
Description: TTMI TTM Technologies January 10, 2026
TTM Technologies Inc. (NASDAQ:TTMI) designs, manufactures, and sells mission-critical RF components, microwave/microelectronic assemblies, and printed circuit boards (PCBs) across two segments-PCB and RF & S Components-serving OEMs, EMS providers, and government customers in aerospace & defense, data-center, automotive, medical, and industrial markets.
Key product lines include high-density interconnect (HDI) and flexible PCBs, advanced ceramic RF parts, beam-forming and switching networks, and maritime/airborne radar systems such as the AN/APS-153 and MOSAIC-brand AESA radars. The firm also offers value-added services like design-for-manufacturability, rapid prototyping, and thermal-management testing, positioning itself as a one-stop supplier for complex electronic assemblies.
Recent metrics (FY 2023) show revenue of roughly $1.3 billion with a gross margin near 23%, and a backlog exceeding $1.5 billion-indicating strong order flow. The company’s performance is tied to two macro drivers: (1) sustained U.S. defense spending, which has risen ~5% YoY and underpins demand for radar and high-reliability RF systems; and (2) a growing global PCB market, projected to expand at ~8% CAGR through 2028, driven by data-center and automotive electrification trends. Supply-chain pressures on copper and semiconductor components remain a material risk to margins.
For a deeper dive into TTMI’s valuation multiples and forward-looking financial models, you might explore the analysis tools available on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 177.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA 0.28 > 1.0 |
| NWC/Revenue: 30.73% < 20% (prev 32.66%; Δ -1.92% < -1%) |
| CFO/TA 0.08 > 3% & CFO 315.0m > Net Income 177.4m |
| Net Debt (414.9m) to EBITDA (402.8m): 1.03 < 3 |
| Current Ratio: 1.93 > 1.5 & < 3 |
| Outstanding Shares: last quarter (106.6m) vs 12m ago 1.93% < -2% |
| Gross Margin: 20.33% > 18% (prev 0.20%; Δ 2013 % > 0.5%) |
| Asset Turnover: 79.49% > 50% (prev 70.35%; Δ 9.14% > 0%) |
| Interest Coverage Ratio: 5.64 > 6 (EBITDA TTM 402.8m / Interest Expense TTM 45.3m) |
Altman Z'' 4.47
| A: 0.23 (Total Current Assets 1.86b - Total Current Liabilities 962.2m) / Total Assets 3.84b |
| B: 0.25 (Retained Earnings 965.2m / Total Assets 3.84b) |
| C: 0.07 (EBIT TTM 255.7m / Avg Total Assets 3.66b) |
| D: 1.58 (Book Value of Equity 1.76b / Total Liabilities 1.12b) |
| Altman-Z'' Score: 4.47 = AA |
Beneish M -3.34
| DSRI: 0.57 (Receivables 563.7m/830.0m, Revenue 2.91b/2.44b) |
| GMI: 0.96 (GM 20.33% / 19.54%) |
| AQI: 0.96 (AQ_t 0.25 / AQ_t-1 0.26) |
| SGI: 1.19 (Revenue 2.91b / 2.44b) |
| TATA: -0.04 (NI 177.4m - CFO 315.0m) / TA 3.84b) |
| Beneish M-Score: -3.34 (Cap -4..+1) = AA |
What is the price of TTMI shares?
Over the past week, the price has changed by +0.39%, over one month by +39.93%, over three months by +44.74% and over the past year by +268.94%.
Is TTMI a buy, sell or hold?
- StrongBuy: 3
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the TTMI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 118.5 | 20.2% |
| Analysts Target Price | 118.5 | 20.2% |
| ValueRay Target Price | 161.3 | 63.6% |
TTMI Fundamental Data Overview February 07, 2026
P/S = 3.4374
P/B = 5.8435
P/EG = 0.52
Revenue TTM = 2.91b USD
EBIT TTM = 255.7m USD
EBITDA TTM = 402.8m USD
Long Term Debt = 912.8m USD (from longTermDebt, two quarters ago)
Short Term Debt = 3.81m USD (from shortTermDebt, last quarter)
Debt = 916.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 414.9m USD (from netDebt column, last quarter)
Enterprise Value = 9.98b USD (9.57b + Debt 916.2m - CCE 501.2m)
Interest Coverage Ratio = 5.64 (Ebit TTM 255.7m / Interest Expense TTM 45.3m)
EV/FCF = 278.8x (Enterprise Value 9.98b / FCF TTM 35.8m)
FCF Yield = 0.36% (FCF TTM 35.8m / Enterprise Value 9.98b)
FCF Margin = 1.23% (FCF TTM 35.8m / Revenue TTM 2.91b)
Net Margin = 6.11% (Net Income TTM 177.4m / Revenue TTM 2.91b)
Gross Margin = 20.33% ((Revenue TTM 2.91b - Cost of Revenue TTM 2.32b) / Revenue TTM)
Gross Margin QoQ = 20.01% (prev 20.82%)
Tobins Q-Ratio = 2.60 (Enterprise Value 9.98b / Total Assets 3.84b)
Interest Expense / Debt = 1.35% (Interest Expense 12.4m / Debt 916.2m)
Taxrate = 18.26% (11.3m / 62.0m)
NOPAT = 209.0m (EBIT 255.7m * (1 - 18.26%))
Current Ratio = 1.93 (Total Current Assets 1.86b / Total Current Liabilities 962.2m)
Debt / Equity = 0.52 (Debt 916.2m / totalStockholderEquity, last quarter 1.76b)
Debt / EBITDA = 1.03 (Net Debt 414.9m / EBITDA 402.8m)
Debt / FCF = 11.59 (Net Debt 414.9m / FCF TTM 35.8m)
Total Stockholder Equity = 1.67b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.85% (Net Income 177.4m / Total Assets 3.84b)
RoE = 10.61% (Net Income TTM 177.4m / Total Stockholder Equity 1.67b)
RoCE = 9.89% (EBIT 255.7m / Capital Employed (Equity 1.67b + L.T.Debt 912.8m))
RoIC = 8.17% (NOPAT 209.0m / Invested Capital 2.56b)
WACC = 11.66% (E(9.57b)/V(10.48b) * Re(12.67%) + D(916.2m)/V(10.48b) * Rd(1.35%) * (1-Tc(0.18)))
Discount Rate = 12.67% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.09%
[DCF Debug] Terminal Value 62.94% ; FCFF base≈30.5m ; Y1≈26.6m ; Y5≈21.3m
Fair Price DCF = N/A (negative equity: EV 229.5m - Net Debt 414.9m = -185.4m; debt exceeds intrinsic value)
EPS Correlation: 56.54 | EPS CAGR: 33.04% | SUE: 1.91 | # QB: 5
Revenue Correlation: 64.18 | Revenue CAGR: 7.95% | SUE: 1.10 | # QB: 4
EPS next Quarter (2026-03-31): EPS=0.67 | Chg30d=+0.042 | Revisions Net=-2 | Analysts=4
EPS current Year (2026-12-31): EPS=3.21 | Chg30d=+0.350 | Revisions Net=+2 | Growth EPS=+30.5% | Growth Revenue=+17.2%
EPS next Year (2027-12-31): EPS=4.49 | Chg30d=+1.173 | Revisions Net=+2 | Growth EPS=+39.9% | Growth Revenue=+17.3%